shp 77 (ATCC)
95
Structured Review
ATCC
shp 77
Shp 77, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shp+77/SHP-77/pm42189233-179-0-1
Average 95 stars, based on 137 article reviews
Shp 77, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shp+77/SHP-77/pm42189233-179-0-1
Average 95 stars, based on 137 article reviews
shp 77 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Staining:Article Title: DLL3 targeting chimeric antigen receptors and binding agents Article Snippet: Anti-DLL3 antibodies were first screened in Flag-DLL3 (adipogen) ELISA and then screened in FACS to determine binding to HEK-293T cells with or without human DLL3 expression. .. To test if the DLL3 specific antibodies can recognize cells that express endogenous DLL3, DMS 273 (Sigma, cat #95062830), DMS 454 (Sigma, cat #95062832), and Purification:Article Title: DLL3 targeting chimeric antigen receptors and binding agents Article Snippet: Anti-DLL3 antibodies were first screened in Flag-DLL3 (adipogen) ELISA and then screened in FACS to determine binding to HEK-293T cells with or without human DLL3 expression. .. To test if the DLL3 specific antibodies can recognize cells that express endogenous DLL3, DMS 273 (Sigma, cat #95062830), DMS 454 (Sigma, cat #95062832), and Control:Article Title: DLL3 targeting chimeric antigen receptors and binding agents Article Snippet: Anti-DLL3 antibodies were first screened in Flag-DLL3 (adipogen) ELISA and then screened in FACS to determine binding to HEK-293T cells with or without human DLL3 expression. .. To test if the DLL3 specific antibodies can recognize cells that express endogenous DLL3, DMS 273 (Sigma, cat #95062830), DMS 454 (Sigma, cat #95062832), and Cell Culture:Article Title: IAR025, a novel anti-DLL3 x CD3-bispecific antibody, displays high antitumor efficacy in preclinical models of small-cell lung cancer. Article Snippet: All cancer cell lines were obtained from ATCC. .. |